Reata pharmaceuticals inc investor relations：Reata Pharmaceuticals (RETA) Investor Relations Material

Reata Pharmaceuticals (RETA) Investor Relations Material

AccessReataPharmaceuticalsInc(RETA)InvestorRelationsmaterial,suchasLiveEarningsCalls,Transcripts,Slides,Reports,andEstimatesusingQuartr.。其他文章還包含有：「BiogentoAcquireReataPharmaceuticals」、「DEFA14A」、「ReataPharmaceuticals」、「ReataPharmaceuticals2023AnnualMeeting」、「ReataPharmaceuticals」、「ReataPharmaceuticals」、「ReataPharmaceuticals」

查看更多離開網站

Reata Pharmaceuticals

Provide From Google

Biogen to Acquire Reata Pharmaceuticals

https://investors.biogen.com

Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion.

Provide From Google

DEFA14A

https://www.sec.gov

On July 28, 2023, Biogen Inc. (the “Company”) and Reata Pharmaceuticals, Inc. (“Reata”) issued a joint press release announcing the entry ...

Provide From Google

Reata Pharmaceuticals

https://www.biogen.com

Reata Pharmaceuticals has been acquired by Biogen.

Provide From Google

Reata Pharmaceuticals 2023 Annual Meeting

https://www.proxydocs.com

Annual Meeting. The annual meeting of Reata Pharmaceuticals will be held on Wednesday, June 7, 2023, at 8:00 AM Central Time. The meeting will only be held ...

Provide From Google